Changes in coagulation and hemodynamics during pregnancy: A prospective longitudinal study of 58 cases

Archives of Gynecology and Obstetrics

Volumn 285, Issue 5, 2012, Pages 1231-1236

  Hui, Chen ^a   Lili, Meng ^a   Libin, Chen ^a   Rui, Zhang ^a   Fang, Guo ^b   Ling, Gao ^c   Jianping, Zhang ^a  

^a SUN YAT SEN MEMORIAL HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU WOMEN AND CHILDREN S MEDICAL CENTER   (China)

^c THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Hemodynamics; Hemostasis; Pregnancy; Ultrasound

Indexed keywords

D DIMER; FIBRINOGEN; FIBRONECTIN; PLASMINOGEN ACTIVATOR INHIBITOR 2; PROTHROMBIN; THROMBOMODULIN; THROMBOXANE B2;

ADULT; ARTERY RESISTANCE; BLOOD CLOTTING; CONTROLLED STUDY; DIASTOLE; FEMALE; HEMODYNAMICS; HUMAN; INTERNATIONAL NORMALIZED RATIO; LONGITUDINAL STUDY; PARTIAL THROMBOPLASTIN TIME; PREGNANCY; PROSPECTIVE STUDY; PROTHROMBIN TIME; PULSE RATE; REVIEW; SECOND TRIMESTER PREGNANCY; SYSTOLE; THIRD TRIMESTER PREGNANCY; THROMBIN TIME; UTERINE ARTERY; ARTICLE; BLOOD SAMPLING; FIBRINOLYSIS; FIRST TRIMESTER PREGNANCY; HEMODYNAMIC MONITORING; PULSATILE FLOW; UMBILICAL ARTERY; VASCULAR RESISTANCE;

ADULT; BLOOD COAGULATION; BLOOD COAGULATION TESTS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOGEN; FIBRONECTINS; HEMODYNAMICS; HUMANS; LONGITUDINAL STUDIES; PEPTIDE FRAGMENTS; PLASMINOGEN ACTIVATOR INHIBITOR 2; PREGNANCY; PROSPECTIVE STUDIES; PROTHROMBIN; THROMBOMODULIN; THROMBOXANE B2; YOUNG ADULT;

EID: 84862765168     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-011-2137-x     Document Type: Review

References (35)

1. Greer IA (1999) Thrombosis in pregnancy: maternal and fetal issues. Lancet 353:1258-1265 (Pubitemid 29168473)
2. Pabinger I (2009) Thrombophilia and its impact on pregnancy. Thromb Res 123:S16-S21
3. Said JM (2011) The role of proteoglycans in contributing to placental thrombosis and fetal growth restriction. J Pregnancy 2011:928381
4. James AH (2009) Pregnancy-associated thrombosis. Hematol Am Soc Hematol Educ Progr 2009:277-285
5. Rodger M (2010) Evidence base for the management of venous thromboembolism in pregnancy. Hematol Am Soc Hematol Educ Progr 2010:173-180
6. Vora S, Ghosh K, Shetty S, Salvi V, Satoskar P (2007) Deep venous thrombosis in the antenatal period in a large cohort of pregnancies from western India. Thromb J 5:9
7. Stortoni P, Cecati M, Giannubilo SR, Sartini D, Turi A, Emanuelli M, Tranquilli AL (2010) Placental thrombomodulin expression in recurrent miscarriage. Reprod Biol Endocrinol 8:1
8. Sucak GT, Acar K, Sucak A, Kirazli S, Haznedar R (2006)Increased globalfibrinolyticcapacityasaclueforactivatedfibrinolysisinpreeclampsia.Blood Coagul Fibrinolysis17:347-352
9. Wikström AK, Nash P, Eriksson UJ, Olovsson MH (2009) Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia. Am J Obstet Gynecol 201:5971.e1-5971.e8
10. Villarreal C, García-Aguirre G, Hernández C, Vega O, Borbolla JR, Collados MT (2002) Congenital thrombophilia associated to obstetric complications. J Thromb Thrombolysis 14:163-169 (Pubitemid 36559684)
11. Alijotas-Reig J, Vilardell-Tarres M (2010) Is obstetric antiphospholipid syndrome a primary nonthrombotic, proinflammatory, complement-mediated disorder related to antiphospholipid antibodies? Obstet Gynecol Surv 65:39-45
12. Borrelli AL, De Lucia D, Bernacchi M, Napolitano M, Di Domenico A, Felicetti M, Ferrara C, Meo D, Raffio R, Rivetti A, Sessa M, Tagliaferri A, Torella M (2006) Haemocoagulative modifications correlated with pregnancy. Minerva Ginecol 58(4):315-322 (Pubitemid 44476707)
13. Cerneca F, Ricci G, Simeone R, Malisano M, Alberico S, Guaschino S (1997) Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis. Eur J Obstet Gynecol Reprod Biol 73:31-36 (Pubitemid 27224457)
14. Yoshida A, Nakao S, Kobayashi M, Kobayashi H (2000) Flowmediated vasodilation and plasma fibronectin levels in preeclampsia. Hypertension 36:400-404
15. Pulkkinen MO, Lehto M, Jalkanen M, Näntö-Salonen K (1984) Collagen types and fibronectin in the uterine muscle of normal and hypertensive pregnant patients. Am J Obstet Gynecol 149:711-717 (Pubitemid 14054197)
16. Dane C, Buyukasik H, Dane B, Yayla M (2009) Maternal plasma fibronectin and advanced oxidative protein products for the prediction of preeclampsia in high risk pregnancies: a prospective cohort study. Fetal Diagn Ther 26:189-194
17. Bowen RS, Zhang Y, Gu Y, Lewis DF, Wang Y (2005) Increased phospholipase A2 and thromboxane but not prostacyclin production by placental trophoblast cells from normal and preeclampticpregnanciesculturedunderhypoxiacondition. Placenta 26:402-409 (Pubitemid 40567918)
18. Zhao S, Gu Y, Lewis DF, Wang Y (2008) Predominant basal directional release of thromboxane, but not prostacyclin, by placental trophoblasts from normal and preeclamptic pregnancies. Placenta 29:81-88
19. Maiello M, Torella M, Caserta L, Caserta R, Sessa M, Tagliaferri A, Bernacchi M, Napolitano M, Nappo C, De Lucia D, Panariello S (2006) Hypercoagulability during pregnancy: evidences for a thrombophilic state. Minerva Ginecol 58:417-422 (Pubitemid 44726987)
20. Kjellberg U, Andersson N, Rosén S, Tengborn L, Hellgren M (1999) APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 81:527-531 (Pubitemid 29178935)
21. Brenner B (2004) Haemostatic changes in pregnancy. Thromb Res 114:409-414 (Pubitemid 39422573)
22. Boffa MC, Valsecchi L, Fausto A, Gozin D, Vigano' D'Angelo S, Safa O, Castiglioni MT, Amiral J, D0Angelo A (1998) Predictive value of plasma thrombomodulin in preeclampsia and gestational hypertension. Thromb Haemost 79:1092-1095 (Pubitemid 28297152)
23. Rousseau A, Favier R, Van Dreden P (2009) Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol 146:46-49
24. Nadar SK, Al Yemeni E, Blann AD, Lip GYH (2004) Thrombomodulin, von Willebrand factor and E-selectin as plasma markers of endothelial damage/dysfunction and activation in pregnancy induced hypertension. Thromb Res 113:123-128 (Pubitemid 38534489)
25. Hunt BJ, Missfelder-Lobos H, Parra-Cordero M, Fletcher O, Parmar K, Lefkou E, Lees CC (2009) Pregnancy outcome and fibrinolytic, endothelial and coagulation markers in women undergoing uterine artery Doppler screening at 23 weeks. J Thromb Haemost 7:955-961
26. Coolman M, de Groot CJ, Steegers EA, Geurts-Moespot A, Thomas CM, Steegers-Theunissen RP, Sweep FC (2006)Concentrationsof plasminogen activators and their inhibitors in blood preconceptionally, duringandafterpregnancy.Eur JObstet Gynecol Reprod Biol128:22-28 (Pubitemid 44311352)
27. Chinni E, Colaizzo D, Tiscia GL, Martinelli P, Maruotti GM, Matteo M, Margaglione M, Grandone E (2010) Markers of haemostasis and angiogenesis in placentae from gestational vascular complications: impairment of mechanisms involved in maintaining intervillous blood flow. Thromb Res 125:267-271
28. Nielsen AH, Schauser KH, Poulsen K (2000) Current topic: the uteroplacental renin-angiotensin system. Placenta 21:468-477 (Pubitemid 30609350)
29. Myatt L (1992) Control of vascular resistance in the human placenta. Placenta 13:329-341
30. Rizzo G, Capponi A, Cavicchioni O, Vendola M, Arduini D (2008) First trimester uterine Doppler and three-dimensional ultrasound placental volume calculation in predicting preeclampsia. Eur J Obstet Gynecol Reprod Biol 38:147-151 (Pubitemid 351726049)
31. Dugoff L, Lynch AM, Cioffi-Ragan D, Hobbins JC, Schultz LK, Malone FD, D0Alton ME; FASTER Trial Research Consortium (2005)Firsttrimesteruterineartery Dopplerabnormalitiespredict subsequent intrauterine growth restriction. Am J Obstet Gynecol 193:1208-1212 (Pubitemid 41285521)
32. Misra VK, Hobel CJ, Sing CF (2009) Placental Blood Flow and the Risk of Preterm Delivery. Placenta 30:619-624
33. Fratelli N, Rampello S, Guala M, Platto C, Frusca T (2008) Transabdominal uterine artery Doppler between 11 and 14 weeks of gestation for the prediction of outcome in high-risk pregnancies. J Matern Fetal Neonatal Med 21:403-406 (Pubitemid 351999176)
34. Lees C, Parra M, Missfelder-Lobos H, Morgans A, Fletcher O, Nicolaides KH (2001) Individualized risk assessment for adverse pregnancyoutcomebyuterineartery Dopplerat23 weeks.Obstet Gynecol 98:369-373
35. Tchirikov M, Strohner M, Förster D, Hüneke B (2009) A combinationof umbilicalartery PIandnormalizedbloodflowvolume in the umbilical vein: venous-arterial index for the prediction of fetal outcome. Eur J Obstet Gynecol Reprod Biol 142:129-133